This spring, TIDES held a hybrid event in Boston presenting the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products.
In this eBook we not only dive into the newest technological advances in the mRNA industry, but also delve into analytical methods, manufacturing techniques, industry roadmaps, and more. The next pages include insights from Asahi Kasei Bioprocess, Moderna, BioNTech, Sarepta Therapeutics, Biogen, and more.